Novel targeted therapies in acute lymphoblastic leukemia.

Novel targeted therapies in acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q38120551
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsFeasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology GroupCurrent status of antibody therapy in ALL.Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin's lymphomas.Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemiaAllogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.
P2860

Novel targeted therapies in acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q38120551
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel targeted therapies in acute lymphoblastic leukemia.
@en
type
label
Novel targeted therapies in acute lymphoblastic leukemia.
@en
prefLabel
Novel targeted therapies in acute lymphoblastic leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Novel targeted therapies in acute lymphoblastic leukemia.
@en
P2093
P2860
P304
P31
P356
10.3109/10428194.2013.823493
P433
P478
P50
P577
P698